Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Neuroscience. 2010 Jun 19;169(4):1848–1859. doi: 10.1016/j.neuroscience.2010.05.052

TABLE 1.

GLUTAMATE LEVELS FOLLOWING SYSTEMIC INJECTIONS: GROUP MICROELECTRODE DATA

MEASURE KYNURENINE (25 mg/kg) KYNURENINE (50 mg/kg) GALANTAMINE (3 mg/kg) + KYNURENINE (50 mg/kg)
BASAL GLUTAMATE (μM) 6.0 ± 1.3 6.2 ± 1.4 6.5 ± 1.6
POST-INJECTION GLUTAMATE (% CHANGE FROM BASAL) 5.4 ± 1.2 ( −10.6 ±1.1a) 4.4 ± 1.1 (−30.8 ± 5.0) 5.7 ± 1.4 (−10.8 ± 2.3a)
TIME TO EFFECT (min) 16.2 ± 4.9 5.4 ± 3.6 16.3 ± 8.9
TIME TO MAX EFFECT (min) 111.2 ± 23.3a 314.0 ± 20.0 77.8 ± 20.2a
DURATION OF EFFECT (min) 210.3 ± 21.6a > 6 hr 146.6 ± 13.4a,b

All pharmacological treatments were administered via intraperitoneal (i.p.) injections. Values are means ± S.E.M. with n = 5 rats/treatment group.

a

= significantly different from kynurenine (50 mg/kg)

b

= significantly different from kynurenine (25 mg/kg)

HHS Vulnerability Disclosure